EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Regulatory T Cells in Health and Disease

Mingyi Li iD, Si Zhang, Tangchun Wu, Tingting Tang, Xiang Cheng

MedComm · 2026-11 · 7 (11)

DOI: 10.1002/mco2.71107 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 09.11.2026. Verfasst von Mingyi Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan China. Die Arbeit nennt 337 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regulatory T cells (Tregs) are central guardians of immune tolerance and tissue homeostasis. Initially defined as suppressors of excessive immune responses, Tregs are now recognized as adaptable cells that integrate antigenic, cytokine, metabolic, and tissue‐derived signals to coordinate immune regulation, inflammation resolution, and tissue repair. However, these dimensions are often considered separately, and their interrelationships across physiological and pathological contexts remain insufficiently integrated. Here, we summarize the developmental origin, lineage stability, plasticity, and tissue adaptation of Tregs, and examine how these features shape their context‐dependent functions. In lymphoid organs, Tregs maintain systemic tolerance by limiting antigen‐presenting cell activation, restraining IL‐2 availability, and setting the threshold for T‐ and B‐cell responses, whereas in non‐lymphoid tissues, they acquire organ‐specific transcriptional, metabolic, and migratory programs that support barrier integrity, metabolic fitness, and regenerative repair. Chronic inflammation, persistent antigenic stimulation, oxidative stress, and metabolic disturbance can in turn disrupt these programs, promoting functional reprogramming or lineage instability, while excessive Treg‐mediated suppression may favor pathogen persistence and tumor immune escape. We further discuss Treg alterations across major disease settings and emerging Treg‐targeted therapies, providing an integrated framework that links developmental origin, tissue context, and functional state to more precise therapeutic strategies.

Schlagwörter

Stichwörter der Autor:innen

cell plasticitycell‐based therapyimmune homeostasisregulatory T cellstissue adaptation

Autor:innen und Institutionen

  • Department of Cardiology Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan China.
  • Hubei Key Laboratory of Biological Targeted Therapy Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan China.
  • Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan China.
  • Department of Occupational and Environmental Health School of Public Health Tongji Medical College, Huazhong University of Science and Technology Wuhan China.

ORCID-Profile: Mingyi Li

Zitieren

APA

Li, M., Zhang, S., Wu, T., Tang, T., & Cheng, X. (2026). Regulatory T Cells in Health and Disease. MedComm, 7(11). https://doi.org/10.1002/mco2.71107

Vancouver

Li M, Zhang S, Wu T, Tang T, Cheng X. Regulatory T Cells in Health and Disease. MedComm. 2026;7(11). doi:10.1002/mco2.71107

BibTeX
@article{Li2026,
  author = {Li, Mingyi and Zhang, Si and Wu, Tangchun and Tang, Tingting and Cheng, Xiang},
  title = {Regulatory T Cells in Health and Disease},
  journal = {MedComm},
  year = {2026},
  volume = {7},
  number = {11},
  doi = {10.1002/mco2.71107}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche